Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML

Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by FLT3 internal tandem duplication (FLT3 ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantat...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in hematology 2016-01, Vol.2016 (2016), p.1-7
Main Authors: Wang, Eunice S., Starostik, Petr, Deeb, George, Evans, Andrew, Mendler, Jason H., Vachhani, Pankit, Wallace, Paul K.
Format: Article
Language:English
Subjects:
Biopsy
Blood
Bone marrow
Cancer
Cancer therapies
Case Report
Chemotherapy
Colleges & universities
Cytogenetics
Drug dosages
Family medical history
Immune system
Laboratories
Leukemia
Medical prognosis
Medicine
Mutation
Pathology
Patients
Stem cells
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c463t-6c9e50ed3be5719362934cf8d06f3c480c271ff0d321e713c9f25584211ecba73
cites cdi_FETCH-LOGICAL-c463t-6c9e50ed3be5719362934cf8d06f3c480c271ff0d321e713c9f25584211ecba73
container_end_page 7
container_issue 2016
container_start_page 1
container_title Case reports in hematology
container_volume 2016
creator Wang, Eunice S.
Starostik, Petr
Deeb, George
Evans, Andrew
Mendler, Jason H.
Vachhani, Pankit
Wallace, Paul K.
description Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by FLT3 internal tandem duplication (FLT3 ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. We report here the first case of SR of FLT3 ITD mutant AML in the literature. Our patient was an elderly woman with relapsed NPM1 and FLT3 ITD mutant AML whose disease underwent SR for a brief duration without precipitating cause. We review the potential immune mechanisms underlying SR in AML and discuss the implications for novel immunotherapeutic approaches for FLT3 mutant AML.
doi_str_mv 10.1155/2016/1259759
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5c705a52b82b46c0962515b2d47f3465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A550614145</galeid><doaj_id>oai_doaj_org_article_5c705a52b82b46c0962515b2d47f3465</doaj_id><sourcerecordid>A550614145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-6c9e50ed3be5719362934cf8d06f3c480c271ff0d321e713c9f25584211ecba73</originalsourceid><addsrcrecordid>eNqNkk1vEzEQhlcIRKvSG2e0EkdI6_Hn7gUpKhQiUhVBOFtefySOEju1d6n67-s0IRCJA_bB1viZ1zP2W1WvAV0AMHaJEfBLwKwVrH1WnWLUohFnon1-2HN0Up3nvERlcIQJgZfVCW4ACyrEafX1xyaGXgUbh1x_t2ufs4-h9qFWob5dGZvqb6r3NvT1ve8XBVmpTbamvp7OSD2ZfaxvhpLe1-Ob6avqhVOrbM_361n18_rT7OrLaHr7eXI1no405aQfcd1ahqwhnWUCWsJxS6h2jUHcEU0bpLEA55AhGKwAoluHGWsoBrC6U4KcVZOdrolqKTfJr1V6kFF5-RSIaS5V6r1eWcm0QEwx3DW4o1yjlmMGrMOGCkcoZ0Xrw05rM3Rra3RpNKnVkejxSfALOY-_JMOlStwUgbd7gRTvBpt7uYxDCqV_CQ3HgAl6umZPzVWpygcXi5gur63lmDHEgQLdUhf_oMo05WN0DNb5Ej9KeL9L0CnmnKw7FA5Ibg0itwaRe4MU_M3fzR7g33YowLsdsPDBqHv_n3K2MNapPzQg1BBEHgEIIseJ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1862123065</pqid></control><display><type>article</type><title>Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Wang, Eunice S. ; Starostik, Petr ; Deeb, George ; Evans, Andrew ; Mendler, Jason H. ; Vachhani, Pankit ; Wallace, Paul K.</creator><contributor>Langabeer, Stephen</contributor><creatorcontrib>Wang, Eunice S. ; Starostik, Petr ; Deeb, George ; Evans, Andrew ; Mendler, Jason H. ; Vachhani, Pankit ; Wallace, Paul K. ; Langabeer, Stephen</creatorcontrib><description>Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by FLT3 internal tandem duplication (FLT3 ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. We report here the first case of SR of FLT3 ITD mutant AML in the literature. Our patient was an elderly woman with relapsed NPM1 and FLT3 ITD mutant AML whose disease underwent SR for a brief duration without precipitating cause. We review the potential immune mechanisms underlying SR in AML and discuss the implications for novel immunotherapeutic approaches for FLT3 mutant AML.</description><identifier>ISSN: 2090-6560</identifier><identifier>EISSN: 2090-6579</identifier><identifier>DOI: 10.1155/2016/1259759</identifier><identifier>PMID: 28127477</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Biopsy ; Blood ; Bone marrow ; Cancer ; Cancer therapies ; Case Report ; Chemotherapy ; Colleges &amp; universities ; Cytogenetics ; Drug dosages ; Family medical history ; Immune system ; Laboratories ; Leukemia ; Medical prognosis ; Medicine ; Mutation ; Pathology ; Patients ; Stem cells ; Transplants &amp; implants</subject><ispartof>Case reports in hematology, 2016-01, Vol.2016 (2016), p.1-7</ispartof><rights>Copyright © 2016 Pankit Vachhani et al.</rights><rights>COPYRIGHT 2017 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2016 Pankit Vachhani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2016 Pankit Vachhani et al. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-6c9e50ed3be5719362934cf8d06f3c480c271ff0d321e713c9f25584211ecba73</citedby><cites>FETCH-LOGICAL-c463t-6c9e50ed3be5719362934cf8d06f3c480c271ff0d321e713c9f25584211ecba73</cites><orcidid>0000-0001-9779-6217</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1862123065/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1862123065?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,44571,53772,53774,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28127477$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Langabeer, Stephen</contributor><creatorcontrib>Wang, Eunice S.</creatorcontrib><creatorcontrib>Starostik, Petr</creatorcontrib><creatorcontrib>Deeb, George</creatorcontrib><creatorcontrib>Evans, Andrew</creatorcontrib><creatorcontrib>Mendler, Jason H.</creatorcontrib><creatorcontrib>Vachhani, Pankit</creatorcontrib><creatorcontrib>Wallace, Paul K.</creatorcontrib><title>Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML</title><title>Case reports in hematology</title><addtitle>Case Rep Hematol</addtitle><description>Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by FLT3 internal tandem duplication (FLT3 ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. We report here the first case of SR of FLT3 ITD mutant AML in the literature. Our patient was an elderly woman with relapsed NPM1 and FLT3 ITD mutant AML whose disease underwent SR for a brief duration without precipitating cause. We review the potential immune mechanisms underlying SR in AML and discuss the implications for novel immunotherapeutic approaches for FLT3 mutant AML.</description><subject>Biopsy</subject><subject>Blood</subject><subject>Bone marrow</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Case Report</subject><subject>Chemotherapy</subject><subject>Colleges &amp; universities</subject><subject>Cytogenetics</subject><subject>Drug dosages</subject><subject>Family medical history</subject><subject>Immune system</subject><subject>Laboratories</subject><subject>Leukemia</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Mutation</subject><subject>Pathology</subject><subject>Patients</subject><subject>Stem cells</subject><subject>Transplants &amp; implants</subject><issn>2090-6560</issn><issn>2090-6579</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkk1vEzEQhlcIRKvSG2e0EkdI6_Hn7gUpKhQiUhVBOFtefySOEju1d6n67-s0IRCJA_bB1viZ1zP2W1WvAV0AMHaJEfBLwKwVrH1WnWLUohFnon1-2HN0Up3nvERlcIQJgZfVCW4ACyrEafX1xyaGXgUbh1x_t2ufs4-h9qFWob5dGZvqb6r3NvT1ve8XBVmpTbamvp7OSD2ZfaxvhpLe1-Ob6avqhVOrbM_361n18_rT7OrLaHr7eXI1no405aQfcd1ahqwhnWUCWsJxS6h2jUHcEU0bpLEA55AhGKwAoluHGWsoBrC6U4KcVZOdrolqKTfJr1V6kFF5-RSIaS5V6r1eWcm0QEwx3DW4o1yjlmMGrMOGCkcoZ0Xrw05rM3Rra3RpNKnVkejxSfALOY-_JMOlStwUgbd7gRTvBpt7uYxDCqV_CQ3HgAl6umZPzVWpygcXi5gur63lmDHEgQLdUhf_oMo05WN0DNb5Ej9KeL9L0CnmnKw7FA5Ibg0itwaRe4MU_M3fzR7g33YowLsdsPDBqHv_n3K2MNapPzQg1BBEHgEIIseJ</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Wang, Eunice S.</creator><creator>Starostik, Petr</creator><creator>Deeb, George</creator><creator>Evans, Andrew</creator><creator>Mendler, Jason H.</creator><creator>Vachhani, Pankit</creator><creator>Wallace, Paul K.</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9779-6217</orcidid></search><sort><creationdate>20160101</creationdate><title>Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML</title><author>Wang, Eunice S. ; Starostik, Petr ; Deeb, George ; Evans, Andrew ; Mendler, Jason H. ; Vachhani, Pankit ; Wallace, Paul K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-6c9e50ed3be5719362934cf8d06f3c480c271ff0d321e713c9f25584211ecba73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biopsy</topic><topic>Blood</topic><topic>Bone marrow</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Case Report</topic><topic>Chemotherapy</topic><topic>Colleges &amp; universities</topic><topic>Cytogenetics</topic><topic>Drug dosages</topic><topic>Family medical history</topic><topic>Immune system</topic><topic>Laboratories</topic><topic>Leukemia</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Mutation</topic><topic>Pathology</topic><topic>Patients</topic><topic>Stem cells</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Eunice S.</creatorcontrib><creatorcontrib>Starostik, Petr</creatorcontrib><creatorcontrib>Deeb, George</creatorcontrib><creatorcontrib>Evans, Andrew</creatorcontrib><creatorcontrib>Mendler, Jason H.</creatorcontrib><creatorcontrib>Vachhani, Pankit</creatorcontrib><creatorcontrib>Wallace, Paul K.</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Case reports in hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Eunice S.</au><au>Starostik, Petr</au><au>Deeb, George</au><au>Evans, Andrew</au><au>Mendler, Jason H.</au><au>Vachhani, Pankit</au><au>Wallace, Paul K.</au><au>Langabeer, Stephen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML</atitle><jtitle>Case reports in hematology</jtitle><addtitle>Case Rep Hematol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2016</volume><issue>2016</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2090-6560</issn><eissn>2090-6579</eissn><abstract>Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by FLT3 internal tandem duplication (FLT3 ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. We report here the first case of SR of FLT3 ITD mutant AML in the literature. Our patient was an elderly woman with relapsed NPM1 and FLT3 ITD mutant AML whose disease underwent SR for a brief duration without precipitating cause. We review the potential immune mechanisms underlying SR in AML and discuss the implications for novel immunotherapeutic approaches for FLT3 mutant AML.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>28127477</pmid><doi>10.1155/2016/1259759</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9779-6217</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-6560
ispartof Case reports in hematology, 2016-01, Vol.2016 (2016), p.1-7
issn 2090-6560
2090-6579
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_5c705a52b82b46c0962515b2d47f3465
source PubMed (Medline); Publicly Available Content Database; Wiley Open Access
subjects Biopsy
Blood
Bone marrow
Cancer
Cancer therapies
Case Report
Chemotherapy
Colleges & universities
Cytogenetics
Drug dosages
Family medical history
Immune system
Laboratories
Leukemia
Medical prognosis
Medicine
Mutation
Pathology
Patients
Stem cells
Transplants & implants
title Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A19%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spontaneous%20Remission%20in%20an%20Older%20Patient%20with%20Relapsed%20FLT3%20ITD%20Mutant%20AML&rft.jtitle=Case%20reports%20in%20hematology&rft.au=Wang,%20Eunice%20S.&rft.date=2016-01-01&rft.volume=2016&rft.issue=2016&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2090-6560&rft.eissn=2090-6579&rft_id=info:doi/10.1155/2016/1259759&rft_dat=%3Cgale_doaj_%3EA550614145%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c463t-6c9e50ed3be5719362934cf8d06f3c480c271ff0d321e713c9f25584211ecba73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1862123065&rft_id=info:pmid/28127477&rft_galeid=A550614145&rfr_iscdi=true